CANF
Can Fite Biopharma Ltd ADR
NYSE MKT: CANF · HEALTHCARE · BIOTECHNOLOGY
$3.10
+3.68% today
Updated 2026-04-30
Market cap
$6.23M
P/E ratio
—
P/S ratio
15.39x
EPS (TTM)
$-10.75
Dividend yield
—
52W range
$3 – $24
Volume
1.4M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.5
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$50.00
+1512.90%
12-Month target
—
—
Intrinsic (DCF)
$9.52
Margin of safety
+53.78%
0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 53.78% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-9.02M
- Revenue declining -43.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $810000.00 | $743000.00 | $674000.00 | $408212.00 | $405000.00 |
| Net income | $-10.24M | $-7.63M | $-7.88M | $-9.91M | $-9.91M |
| EPS | — | — | — | — | $-10.75 |
| Free cash flow | $-10.81M | $-8.44M | $-7.64M | $-9.02M | $-9.02M |
| Profit margin | -1,263.70% | -1,027.46% | -1,169.14% | -2,426.67% | — |
Peer comparison
Smart narrative
Can Fite Biopharma Ltd ADR trades at $3.10. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $405000.00. Our DCF model estimates intrinsic value at $9.52.
Frequently asked questions
What is Can Fite Biopharma Ltd ADR's stock price?
Can Fite Biopharma Ltd ADR (CANF) trades at $3.10.
Is Can Fite Biopharma Ltd ADR overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $9.52.
What is the price target of Can Fite Biopharma Ltd ADR (CANF)?
The analyst target price is $50.00, representing +1512.9% upside from the current price of $3.10.
What is the intrinsic value of Can Fite Biopharma Ltd ADR (CANF)?
Based on our DCF model, intrinsic value is $9.52, a +53.8% margin of safety versus $3.10.
What is Can Fite Biopharma Ltd ADR's revenue?
TTM revenue is $405000.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio15.39x
ROE-178.20%
Beta-0.10
50D MA$3.70
200D MA$8.29
Shares out0.00B
Float0.00B
Short ratio—
Avg volume1.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—